ARTICLE | Company News
Regenetech, Johns Hopkins University deal
November 19, 2007 8:00 AM UTC
The university will use Regenetech's Intrifuge Bioreactor to develop a treatment for Type I diabetes using a patient's own adult stem cells. Regenetech will fund the two-year deal and have an option t...